Skip to main content
Clinical Trials/NCT06511986
NCT06511986
Completed
N/A

Impact of Mechanical Insufflation-Exsufflation on Ventilator-Associated Pneumonia in Post-Neurosurgical Patients: a Safety and Efficacy Study

Beijing Sanbo Brain Hospital1 site in 1 country210 target enrollmentMarch 4, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Ventilator Associated Pneumonia
Sponsor
Beijing Sanbo Brain Hospital
Enrollment
210
Locations
1
Primary Endpoint
Rate of ventilator associated pneumonia
Status
Completed
Last Updated
last year

Overview

Brief Summary

Ventilator-associated pneumonia (VAP) is a common infection in critically ill patients, especially those with acute brain injuries, leading to increased mortality and longer ICU stays.

The mechanical insufflation/exsufflation (M-I/E) cough assist device improves outcomes in patients with neuromuscular disorders but its effects on brain-injured patients are largely unknown.

This study is conducted at a tertiary neurosurgical medical center and consists of two substudies. The prospective physiological study assessed the impact of M-I/E on hemodynamics and ICP in mechanically ventilated neurosurgical patients. The combined retrospective-prospective clinical study was performed to investigate the efficacy of M-I/E on occurence of VAP and other clinical outcomes.

Registry
clinicaltrials.gov
Start Date
March 4, 2024
End Date
March 15, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Beijing Sanbo Brain Hospital
Responsible Party
Principal Investigator
Principal Investigator

Zhonghua Shi, MD, PhD

vice president of dept. ICU

Beijing Sanbo Brain Hospital

Eligibility Criteria

Inclusion Criteria

  • Post-neurosurgical adult patients
  • \>18years old
  • Body mass index (BMI) \<35kg/m2)
  • Receiving mechanical ventilation
  • With arterial blood catheter for continuous pressure measurement and/or ventricular catheter drainage for ICP measurement (only for study one)

Exclusion Criteria

  • ICP \> 22cmH2O or evidence of increased ICP
  • Hemodynamically unstable (SBP\< 90 or \> 160 mmHg; DBP \< 50 or \> 110 mmHg, using cardiovascular medicine to maintain pressure, or known cardiac failure)
  • Patients with lung trauma, emphysema, bronchopleural fistula or risk of pneumothorax
  • History of mechanical ventilation and pneumonia within 6 months before ICU admission

Outcomes

Primary Outcomes

Rate of ventilator associated pneumonia

Time Frame: Within 7 days after the onset of mechanical of ventilation

In study two, ventilator associated pneumonia is defined as pneumonia occurring in patients who have been mechanically ventilated for at least 48 hours. Pneumonia was diagnosed by clinical features (e.g., cough, fever, pleuritic chest pain) and by lung imaging. To derived the diagnosis of pneumonia, patient electronical record, lab results, and images were extracted from the electronical system.

Heart rate

Time Frame: During the process of physiological study, up to 2 hours

In study one, heart rate will be recorded during the incremental pressure changes in the study one

Mean blood pressure

Time Frame: during the process of physiological study, up to 2 hours

In study one, mean blood pressure will be recorded during the incremental pressure changes in the study one

Secondary Outcomes

  • Intracranial pressure(During the process of physiological study, up to 2 hours)
  • Length of stay in ICU(Patients will be followed up until 28 days after surgery, discharged from hospital or dead, which ever came first,through study completion, an average of 1 year)
  • Length of hospital stay(Patients will be followed up until 28 days after surgery, discharged from hospital or dead, which ever came firstthrough study completion, an average of 1 year)
  • Days of receiving mechanical ventilation(Patients will be followed up until 28 days after surgery, discharged from hospital or dead, which ever came firstthrough study completion, an average of 1 year)

Study Sites (1)

Loading locations...

Similar Trials